Rheumatic Disease eJournal Club
IL-6 Receptor Inhibition with
Tocilizumab Improves Treatment
Outcomes in Patients with Rheumatoid Arthritis Refractory to Anti-TNF Biologics: Results from a 24-week Multicentre Randomised Placebo Controlled Trial
Publication: Emery P et al. Ann Rheum Dis. Published online June 2008
This activity has expired.
You will be redirected to our Rheumatology page shortly to find related content in this specialty.
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
